Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery | MicrobiomeTrials← Back to trialsNCT07734766
Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2029-03-01
Enrollment target: 45 participants Other microbiome trials you might be interested in
Decompensated Liver CirrhosisPrimary Biliary CholangitisPrimary Sclerosing CholangitisHepato-cellular Carcinoma
Intro:
The present clinical research protocol is part of the LEOPARD European project (Grant n° 101080964 Horizon Europ…
Vienna, AustriaEst. completion Mar 2028
Decompensated Liver CirrhosisPrimary Biliary CholangitisPrimary Sclerosing CholangitisHepato-cellular Carcinoma
Intro:
The present clinical research protocol is part of the LEOPARD European project (Grant n° 101080964 Horizon Europ…
Ghent, BelgiumEst. completion Jul 7, 2028